Basappa, N. S. (2016). Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Can Urol Assoc J.
Styl cytowania ChicagoBasappa, Naveen S. "Treatment Options in Advanced Renal Cell Carcinoma After First-line Treatment With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors." Can Urol Assoc J 2016.
Styl cytowania MLABasappa, Naveen S. "Treatment Options in Advanced Renal Cell Carcinoma After First-line Treatment With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors." Can Urol Assoc J 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..